Skip to main content
. 2022 Mar 2;4(7):1815–1826. doi: 10.1039/d2na00044j

Fig. 5. In vivo MR imaging of different metabolic organs. (A and B) T1-weighted MRI images of Au–Gd NCs in the liver (white arrowhead), spleen (yellow arrowhead), kidney (blue arrowhead), and bladder (orange arrowhead). (C and D) Quantitative analysis of liver, spleen, kidney, and bladder signal intensity at different time points.

Fig. 5

HHS Vulnerability Disclosure